TABLE 4.
Laboratory Results
| Laboratory Test | Total (N = 88) | Survivor at 30 d (N = 65) | Nonsurvivor at 30 d (N = 23) | p a |
|---|---|---|---|---|
| Peak creatine phosphokinase, median (IQR) (U/L) | 1,214.5 (248.5–3,768.0) | 1,304 (267–5,574) | 683 (205–2,705) | 0.34 |
| WBC at admission, mean (sd) (K/µL) | 15.1 (6.6) | 15.3 (5.8) | 14.8 (8.6) | 0.67 |
| Sodium at admission, mean (sd) (mEq/L) | 133.8 (5.6) | 133.5 (6.1) | 134.6 (4.2) | 0.48 |
| Blood urea nitrogen, median (IQR) (mg/dL) | 30 (19–56) | 26.5 (18–47.5) | 48 (27–74) | 0.01 |
| Creatinine, median (IQR) (mg/dL) | 1.9 (1.2–3.9) | 1.7 (1.2–3.3) | 2.4 (1.5–4.6) | 0.20 |
| Alanine transaminase, median (IQR) (U/L) | 35 (19–77) | 41 (22.5–86.5) | 23 (12–34) | 0.01 |
| Aspartate transaminase, median (IQR) (U/L) | 68 (34–126) | 83 (37–136) | 39 (33–90) | 0.16 |
| Total bilirubin, median (IQR) (mg/dL) | 0.8 (0.5–1.4) | 0.8 (0.5–1.2) | 0.9 (0.5–1.7) | 0.35 |
IQR = interquartile range.
A two-sided p-value of 0.05 or less was considered significant and indicated in bold.
aFisher exact test (categorical), two-sample t test (continuous, normal), or Wilcoxon Mann-Whitney U test (continuous, nonnormal).